• SENSEX 76,391.39
    -363.66 (--0.47%)
  • BANKNIFTY 56,592.00
    -534.80 (--0.94%)
  • HDFC Bank
    743.25 726.75(%)
  • CIE Automotive
    411.35 382.20(%)
  • Oracle Fin.Serv.
    9,950.00 6,232.20(%)
  • Bluestone Jewel
    732.05 400.40(%)
  • Bharti Airtel
    1,925.60 1,745.00(%)
  • Reliance Industries
    1,268.00 1,253.65(%)
  • Bajaj Finance
    1,037.00 788.40(%)
  • Bajaj Finserv
    1,900.15 2,194.65(%)
  • Tanla Platforms
    656.70 765.75(%)
  • Maruti Suzuki
    13,371.65 12,202.10(%)
  • Gandhar Oil Ref.
    283.85 283.85(%)
  • Route Mobile
    649.90 945.00(%)
  • Eternal
    296.15 368.40(%)
  • Adani Green
    1,372.70 767.00(%)
  • Infosys
    1,032.30 984.00(%)
  • IndusInd Bank
    999.00 710.85(%)
  • SBI
    1,006.50 786.55(%)
  • Axis Bank
    1,219.05 1,041.30(%)
  • CG Power & Ind
    881.00 525.50(%)
  • SBI Funds Mgt.
    575.35 575.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astrazeneca Pharma India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 39.0
  • ISIN : INE203A01020
7,872.00 -159 (-1.98%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    7,850.00

  • Today’s High

    8,048.50

  • Open

    7,970.50

  • Perv Close

    8,031.00

  • 52W Low

    7,551.50

  • 52W High

    9,849.50

Key Indicators

  • P/E(TTM)

    102.90

  • Mar.Cap (₹Cr.)

    19,680.00

  • Div & Yield %

    0.46

  • Book Value(₹)

    349.12

  • Debt-Equity Ratio

    -1.98

  • AGM Date

    23-Jul-2026

  • EPS

    76.52

  • P/E Ratio

    102.90

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    19,680.00

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.00

  • BV (₹)

    349.10

  • Sales( ₹ in Cr.)

    2,275.58

  • NP (in Cr.)

    191.31

  • NP Var(%)

    9.0

  • Div%

    1800.0

  • CPS (₹)

    88.00

  • EPS (₹)

    76.50

  • Traded Value (₹ in Lakhs)

    19,684.00

  • 52 Week High

    9,849.50

  • 52 Week Low

    7,551.50

  • Price BSE

    7874.0

  • Price NSE

    7,872.00

  • Market Capital( in Cr.)

    19,684.00

  • P/C Ratio

    89.50

  • P/E Ratio

    102.90

  • Price Vs.BV

    76.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,275.58 1,716.29 1,295.53 1,002.97 805.60 813.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,275.58 1,716.29 1,295.53 1,002.97 805.60 813.56
Other Income 28.49 40.63 51.23 26.10 14.76 12.84
Stock Adjustments 488.37 332.94 33.77 48.86 -14.47 -2.95
Total Income 2,792.44 2,089.86 1,380.53 1,077.93 805.89 823.45
EXPENDITURE :            
Raw Materials 1,868.91 1,295.95 628.33 408.84 297.49 292.00
Power and Fuel Cost 2.88 5.30 4.87 5.54 8.10 7.37
Employee Cost 264.38 257.44 241.45 259.10 230.21 219.54
Other Manufacturing Expenses 20.71 18.45 14.38 13.79 8.05 9.11
Selling and Administration Expenses 313.46 204.87 234.33 185.72 145.09 129.72
Miscellaneous Expenses 36.83 110.04 21.49 53.95 16.01 17.40
Employee Benefit Expenses 264.38 257.44 241.45 259.10 230.21 219.54
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,507.17 1,892.05 1,144.85 926.94 704.95 675.14
Operating Profit 285.27 197.81 235.68 150.99 100.94 148.31
Interest 4.49 1.46 1.20 0.63 0.95 1.09
Gross Profit 280.78 196.35 234.48 150.36 99.99 147.22
Depreciation 28.58 39.99 14.94 16.26 16.95 20.13
Profit Before Tax 252.20 156.36 219.54 134.10 83.04 127.09
Current Tax 59.42 60.54 58.93 38.30 22.63 34.83
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.26 -19.92 -0.90 -3.49 -1.19 -1.04
Reported Net Profit 187.52 115.74 161.51 99.29 61.60 93.30
Extraordinary Items -3.79 -59.39 12.45 -26.96 2.05 1.58
Adjusted Net Profit 191.31 175.13 149.06 126.25 59.55 91.72
Adjustment below Net Profit -4.44 -1.17 1.00 -2.61 -1.74 3.43
P & L Balance brought forward 632.72 578.15 455.64 378.96 324.10 232.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 80.00 60.00 40.00 20.00 5.00 5.00
P & L Balance carried down 735.80 632.72 578.15 455.64 378.96 324.10
Dividend 0.00 0.00 0.00 0.00 5.00 5.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,800.00 1,600.00 1,200.00 800.00 500.00 100.00
Dividend Per Share(Rs) 36.00 32.00 24.00 16.00 10.00 2.00
Earnings Per Share-Unit Curr 75.01 46.30 64.60 39.72 24.64 37.32
Earnings Per Share(Adj)-Unit Curr 75.01 46.30 64.60 39.72 24.64 37.32
Book Value 349.12 308.14 284.77 235.48 204.56 182.47
Book Value(Adj)-Unit Curr 349.12 308.14 284.77 235.48 204.56 182.47

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 18,750,000 75.00 18,750,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 18,750,000 75.00 18,750,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 375 0.00 250 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 670,396 2.68 670,396 97
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,501,271 6.01 1,501,271 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 18,341 0.07 18,341 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,190,383 8.76 2,190,258 114
2] Non Institution
Bodies Corporate 270,903 1.08 270,903 261
Clearing Members 134 0.00 134 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 88,903 0.36 88,403 1,059
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 83,699 0.33 83,698 733
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,528,684 6.11 1,528,684 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,911,587 7.65 1,804,544 27,122
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 333 0.00 333 4
Others 91,272 0.37 91,272 1
Sub Total 4,059,617 16.24 3,952,073 29,223
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 25,000,000 100.00 24,892,331 29,338

Company Background

Astrazeneca Pharma India LtdPharmaceuticals - Multinational

  • Astrazeneca Pharma India Ltd
  • BSE Code : 39.0
  • ISIN : INE203A01020

  • Incorporation Year

    1979

  • Registered Office

    Blk N1 12th Flr Manyata Embass
    Rachenahalli Outer Ring Road, Bangalore,
    Karnataka-560045

  • Telephone

    91-080-67748000

  • FAX

    91-080-67748557

  • Chairman

    Shilpa Divekar Nirula

  • Managing Director

    Praveen Rao Akkinepally

  • Company Secretary

  • Auditor

    Price Waterhouse & Co Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Enterprises (I) Ltd
    No. 30 Ramana Resid.,
    4th Cross Sampige Rd,Malleswaram
    Mumbai - Bangalore - 560003

Astrazeneca Pharma India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astrazeneca Phar 7,873.60 2,304.07 2,275.58 104.97 27.86
Abbott India 28,735.45 7,217.19 6,929.05 39.34 43.78
P & G Health Ltd 6,703.25 944.52 934.17 34.04 71.75
Glaxosmi. Pharma 2,494.20 3,932.76 3,790.20 41.76 58.17
Novartis India 1,668.95 398.23 356.27 44.22 16.64
Cipla 1,393.75 20,102.60 18,979.95 32.03 13.88
Amrutanjan Healt 518.15 469.50 451.82 25.87 21.89
Bliss GVS Pharma 462.85 773.53 729.81 50.70 12.51
Fermenta Biotec. 401.95 474.15 450.25 18.40 18.77
Guj. Themis Bio. 355.30 152.47 150.80 83.01 27.21
Ambalal Sarabhai 32.67 19.52 3.94 22.85 6.77